---
title: "Barclays Keeps Their Buy Rating on Ferrovial (0P2N)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294167850.md"
description: "Barclays analyst Pierre Rousseau maintained a Buy rating on Ferrovial (0P2N) with a €66.00 price target. Rousseau holds a 4-star analyst status. This follows a recent Buy from UBS and contrasts with Citi's Hold rating assigned on July 22."
datetime: "2026-07-29T07:05:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294167850.md)
  - [en](https://longbridge.com/en/news/294167850.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294167850.md)
---

# Barclays Keeps Their Buy Rating on Ferrovial (0P2N)

In a report released today, Pierre Rousseau from Barclays maintained a Buy rating on Ferrovial, with a price target of €66.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Rousseau is a 4-star analyst with an average return of 7.9% and a 57.02% success rate.

In addition to Barclays, Ferrovial also received a Buy from UBS’s Cristian Nedelcu in a report issued on July 23. However, on July 22, Citi assigned a Hold rating to Ferrovial (LSE: 0P2N).

### Related Stocks

- [FER.US](https://longbridge.com/en/quote/FER.US.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)
- [UBS.US](https://longbridge.com/en/quote/UBS.US.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)

## Related News & Research

- [Ferrovial updates investor presentation to correct 407 ETR equity stake data](https://longbridge.com/en/news/294544591.md)
- [Ferrovial publishes investor presentation outlining equity story, infrastructure asset portfolio strategy](https://longbridge.com/en/news/294543685.md)
- [Ferrovial names Sanjay E. Sarma independent non-executive director](https://longbridge.com/en/news/294094603.md)
- [Warburg Research Keeps Their Buy Rating on HENSOLDT AG (HAG)](https://longbridge.com/en/news/294495421.md)
- [Veracyte: Strong Earnings Beat, Raised Guidance and Emerging Diagnostics Portfolio Support Durable Upside, Justifying Buy Rating](https://longbridge.com/en/news/294488048.md)